Janney Montgomery Scott LLC Neurocrine Biosciences Inc Transaction History

Janney Montgomery Scott LLC

$35.8 Billion
Q3 2024

A detailed history of Janney Montgomery Scott LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 16,395 shares of NBIX stock, worth $2.08 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

16,395

Previous 16,808 2.46%

Holding current value

$2.08 Million

Previous $2.31 Million 18.37%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$114.58 - $153.15 $47,321 - $63,250	-413 Reduced 2.46%	16,395 $1.89 Million
Q2 2024 Jul 25, 2024	BUY	$130.86 - $143.19 $1.03 Million - $1.13 Million	7,901 Added 88.71%	16,808 $2.31 Million
Q1 2024 May 01, 2024	BUY	$130.4 - $143.74 $35,208 - $38,809	270 Added 3.13%	8,907 $1.23 Million
Q4 2023 Feb 07, 2024	BUY	$106.07 - $132.76 $427,462 - $535,022	4,030 Added 87.48%	8,637 $1.14 Million
Q3 2023 Nov 08, 2023	BUY	$94.02 - $117.1 $32,718 - $40,750	348 Added 8.17%	4,607 $518,000
Q2 2023 Jul 26, 2023	SELL	$89.53 - $104.87 $3.96 Million - $4.64 Million	-44,204 Reduced 91.21%	4,259 $402,000
Q1 2023 Apr 28, 2023	BUY	$94.11 - $123.02 $325,620 - $425,649	3,460 Added 7.69%	48,463 $4.91 Million
Q4 2022 Feb 01, 2023	BUY	$106.72 - $127.06 $4.39 Million - $5.22 Million	41,119 Added 1058.68%	45,003 $5.38 Million
Q3 2022 Oct 25, 2022	BUY	$92.03 - $107.81 $154,150 - $180,581	1,675 Added 75.83%	3,884 $413,000
Q2 2022 Aug 03, 2022	SELL	$75.79 - $100.07 $80,488 - $106,274	-1,062 Reduced 32.47%	2,209 $215,000
Q1 2022 May 04, 2022	SELL	$72.45 - $94.81 $12,026 - $15,738	-166 Reduced 4.83%	3,271 $307,000
Q4 2021 Jan 27, 2022	SELL	$79.65 - $106.22 $982,403 - $1.31 Million	-12,334 Reduced 78.21%	3,437 $293,000
Q3 2021 Oct 29, 2021	BUY	$86.18 - $99.03 $68,857 - $79,124	799 Added 5.34%	15,771 $1.51 Million
Q2 2021 Jul 26, 2021	SELL	$89.43 - $102.27 $248,973 - $284,719	-2,784 Reduced 15.68%	14,972 $1.46 Million
Q1 2021 Apr 27, 2021	BUY	$87.57 - $119.4 $1.08 Million - $1.48 Million	12,373 Added 229.85%	17,756 $1.73 Million
Q4 2020 Jan 25, 2021	SELL	$86.91 - $108.33 $629,836 - $785,067	-7,247 Reduced 57.38%	5,383 $516,000
Q3 2020 Nov 06, 2020	BUY	$96.16 - $135.15 $71,350 - $100,281	742 Added 6.24%	12,630 $1.22 Million
Q2 2020 Jul 23, 2020	BUY	$85.09 - $130.36 $14,635 - $22,421	172 Added 1.47%	11,888 $1.45 Million
Q1 2020 Apr 30, 2020	BUY	$75.11 - $113.76 $89,981 - $136,284	1,198 Added 11.39%	11,716 $1.01 Million
Q4 2019 Jan 21, 2020	SELL	$86.8 - $118.57 $56,680 - $77,426	-653 Reduced 5.85%	10,518 $1.13 Million
Q3 2019 Oct 29, 2019	BUY	$83.82 - $101.5 $25,900 - $31,363	309 Added 2.84%	11,171 $1.01 Million
Q2 2019 Jul 29, 2019	BUY	$72.24 - $91.27 $111,610 - $141,012	1,545 Added 16.58%	10,862 $917,000
Q1 2019 Apr 30, 2019	BUY	$69.31 - $91.53 $645,761 - $852,785	9,317 New	9,317 $821,000

Others Institutions Holding NBIX

# of Institutions

625

Shares Held

94.7M

Call Options Held

642K

Put Options Held

288K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Account

Janney Montgomery Scott LLC Neurocrine Biosciences Inc Transaction History